GOAL STATEMENT
The goal of this activity is for learners to be better able to accurately diagnosis a developmental and epileptic encephalopathy (DEE) and manage associated seizure and nonseizure symptoms.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have greater competence related to [LIST][ITEM]The accurate diagnosis of a DEE[ITEM]Selection of appropriate antiseizure medication to control seizures in patients with a DEE[ITEM]Development of an appropriate treatment plan to address behavioral or sleep-related symptoms associated with DEEs [/LIST]Demonstrate greater confidence in their ability to[LIST][ITEM]Identify nonseizure symptoms in patients with a DEE [/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hyatt Regency Orlando
Room: Plaza Ballroom D-F (Convention Level)
9801 International Drive
Orlando, Florida, 32819
Opinions presented during this industry-sponsored satellite educational activity are those of the speakers and/or the sponsor and/or the accredited provider of continuing medical education and are not a reflection of American Epilepsy Society opinions, nor are they supported, sponsored or endorsed by the American Epilepsy Society.
Supported by an independent educational grant from [bold]Jazz Pharmaceuticals, Inc.[/bold]